Mesh.i
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Antiviral Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antigens, Viral < Antiviral Agents < Anxiety  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000008 (2001) S. Braun [Allemagne] ; J. Ramaker ; E. Dippel ; C C Zouboulis[Schonlein-Henoch purpura associated with hepatitis B in a patient with HIV infection].
000028 (2003) Anna Oevermann [Suisse] ; Monika Engels ; Ursula Thomas ; Antonio PellegriniThe antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification.
000053 (2005) Jason Paragas [États-Unis] ; Lawrence M. Blatt ; Chris Hartmann ; John W. Huggins ; Tim P. EndyInterferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models.
000133 (2009) Yoon-Suk Lee [Corée du Sud] ; Sun Min Park ; Byeang Hyean KimSynthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses.
000186 (2010) Krishnan Suresh Kumar [Inde] ; Swastika Ganguly ; Ravichandran Veerasamy ; Erik De ClercqSynthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones.
000233 (2011) S K Krishnan [Inde] ; S. Ganguly ; R. Veerasamy ; B. JanSynthesis, antiviral and cytotoxic investigation of 2-phenyl-3-substituted quinazolin-4(3H)-ones.
000254 (2012) Anna-Winona Struck [Allemagne] ; Marco Axmann ; Susanne Pfefferle ; Christian Drosten ; Bernd MeyerA hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2.
000274 (2012) Dirk Jochmans [Belgique] ; Pieter Leyssen ; Johan NeytsA novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE.
000323 (2013) Mi Kyoung Kim [Corée du Sud] ; Hyunjun Yoon ; Dale Lynn Barnard ; Youhoon ChongDesign, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives.
000450 (2014) Mohammad Khalid ; Basha Khan ; Fahad Al Rabiah ; Ruwaida Alismaili ; Sarfraz Saleemi ; Agha Muhammad Rehan-Khaliq ; Ihab Weheba ; Hail Al Abdely ; Magid Halim ; Quaid Johar Nadri ; Abdullah Mohsin Al Dalaan ; Mohamed Zeitouni ; Taimur Butt ; Eid Al MutairyMiddle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia
000760 (2019) Ayman M S. Ahmed [Égypte] ; Reham A I. Abou-Elkhair [Égypte] ; Alaa M. El-Torky [Égypte] ; Abdalla E A. Hassan [Égypte]3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation.
000780 (2019) Mohammed Albratty [Arabie saoudite] ; Karam Ahmed El-Sharkawy [Arabie saoudite] ; Hassan Ahmed Alhazmi [Arabie saoudite]Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents.
000930 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000C32 (2020) Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine]Discovering drugs to treat coronavirus disease 2019 (COVID-19).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Antiviral Agents" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Antiviral Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Antiviral Agents
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021